5-FLuoro-n,n-dimethyl-2-(tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide

Catalog No.: 
ACJJBT145
CAS No.: 
2377609-26-0
Molecular Formula: 
C15H21BFNO3
Molecular Weight: 
293.15
5-FLuoro-n,n-dimethyl-2-(tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$272.00InquiryInquiry
250mg95%$523.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-FLuoro-n,n-dimethyl-2-(tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide
IUPAC Name5-fluoro-N,N-dimethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide
Molecular FormulaC15H21BFNO3
Molecular Weight293.15
SMILESCN(C(C1=C(B2OC(C)(C(C)(O2)C)C)C=CC(F)=C1)=O)C
InChI KeySGMSVQZPBDEFGG-UHFFFAOYSA-N
Synonym5-Fluoro-n,n-dimethyl-2-(tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide;Benzamide, 5-fluoro-N,N-dimethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
CAS No.2377609-26-0

Synthetic Route by SureRoute

1. ACJJBT145 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACJJBT145 route product structure diagram
    ACJJBT1452377609-26-0
Inquiry

2. ACJJBT145 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACUPRQ917 route compound structure diagram
    ACUPRQ9172377607-51-5In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACJJBT145 route product structure diagram
    ACJJBT1452377609-26-0
Inquiry

3. ACJJBT145 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACJJBT145 route product structure diagram
    ACJJBT1452377609-26-0
Inquiry

Comments (0)